DK0521310T3 - Tabletter af faststofdispersionstypen indeholdende 1,4-dihydropyridin-derivater samt fremgangsmåde til fremstilling af såda - Google Patents

Tabletter af faststofdispersionstypen indeholdende 1,4-dihydropyridin-derivater samt fremgangsmåde til fremstilling af såda

Info

Publication number
DK0521310T3
DK0521310T3 DK92109459T DK92109459T DK0521310T3 DK 0521310 T3 DK0521310 T3 DK 0521310T3 DK 92109459 T DK92109459 T DK 92109459T DK 92109459 T DK92109459 T DK 92109459T DK 0521310 T3 DK0521310 T3 DK 0521310T3
Authority
DK
Denmark
Prior art keywords
solid dispersion
substituted
group
unsubstituted alkyl
seed
Prior art date
Application number
DK92109459T
Other languages
Danish (da)
English (en)
Inventor
Daiichi Watanabe
Hiroko Mimachi
Original Assignee
Fujirebio Kk
Ajinomoto Kk
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Fujirebio Kk, Ajinomoto Kk filed Critical Fujirebio Kk
Application granted granted Critical
Publication of DK0521310T3 publication Critical patent/DK0521310T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A61K31/675—Phosphorus compounds having nitrogen as a ring hetero atom, e.g. pyridoxal phosphate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
    • A61K9/146—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic macromolecular compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2077—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Hospice & Palliative Care (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DK92109459T 1991-06-05 1992-06-04 Tabletter af faststofdispersionstypen indeholdende 1,4-dihydropyridin-derivater samt fremgangsmåde til fremstilling af såda DK0521310T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP03134344A JP3110794B2 (ja) 1991-06-05 1991-06-05 １，４−ジヒドロピリジン誘導体を含有する製剤

Publications (1)

Publication Number Publication Date
DK0521310T3 true DK0521310T3 (da) 1999-09-13

Family

ID=15126164

Family Applications (1)

Application Number Title Priority Date Filing Date
DK92109459T DK0521310T3 (da) 1991-06-05 1992-06-04 Tabletter af faststofdispersionstypen indeholdende 1,4-dihydropyridin-derivater samt fremgangsmåde til fremstilling af såda

Country Status (6)

Country Link
EP (1) EP0521310B1 (ko)
JP (1) JP3110794B2 (ko)
KR (1) KR100209201B1 (ko)
AT (1) ATE175874T1 (ko)
DK (1) DK0521310T3 (ko)
ES (1) ES2126579T3 (ko)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SI9300504A (en) * 1993-09-28 1995-04-30 Krka Process for preparation solid dispersions and deposits of calcium antagonist dihidropyrimidine derivates and pharmaceutical compositions comprising the same
EP1120120A4 (en) * 1998-10-05 2009-04-29 Eisai R&D Man Co Ltd TABLETS DISSOLVING DIRECTLY IN MOUTH
PT1239831E (pt) 1999-12-23 2013-01-23 Mayne Pharma International Pty Ltd Composições farmacêuticas melhoradas para fármacos fracamente solúveis
DE60128683T2 (de) * 2000-04-11 2008-01-24 Sankyo Co., Ltd. Stabilisierte pharmazeutische zusammenstellungen die den calziumkanalblocker azelnidipine enthalten
DE10058772A1 (de) * 2000-11-27 2002-06-06 Falk Pharma Gmbh Verfahren zur Herstellung leicht löslicher Arzneimittelformulierungen und entsprechende Formulierungen
KR20040011248A (ko) * 2002-07-30 2004-02-05 환인제약 주식회사 암로디핀의 고체분산체와 그 제조방법 및 그를 포함하는약학적 조성물
US20090304786A1 (en) * 2005-11-25 2009-12-10 Viswaprasad Varanasi Stable Dosage Forms of an Antidepressant
JP5320759B2 (ja) * 2006-04-19 2013-10-23 味の素株式会社 割線錠剤
KR101434316B1 (ko) * 2006-04-19 2014-08-28 아지노모토 가부시키가이샤 고체 분산체의 필름 코팅방법
KR101422052B1 (ko) * 2006-04-19 2014-07-23 아지노모토 가부시키가이샤 할선 정제
KR20100016093A (ko) * 2007-03-30 2010-02-12 아지노모토 가부시키가이샤 고체 분산체 제제
KR101265821B1 (ko) * 2008-01-25 2013-05-20 반도 카가쿠 가부시키가이샤 마찰전동벨트
CN102415998A (zh) * 2010-09-28 2012-04-18 扬子江药业集团北京海燕药业有限公司 盐酸马尼地平固体分散体及其制备方法
KR20150043296A (ko) 2012-06-21 2015-04-22 메인 파마 인터내셔널 프로프라이어터리 리미티드 이트라코나졸 조성물 및 투여형, 그리고 이것들의 사용 방법
JP5854371B2 (ja) * 2012-10-12 2016-02-09 味の素株式会社 カルシウム拮抗薬／アンジオテンシンｉｉ受容体拮抗薬含有医薬製剤

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS542316A (en) * 1977-06-07 1979-01-09 Yamanouchi Pharmaceut Co Ltd Solid pharmaceutical composition containing nifedipene
GB1579818A (en) * 1977-06-07 1980-11-26 Yamanouchi Pharma Co Ltd Nifedipine-containing solid preparation composition
JPS58109411A (ja) * 1981-12-23 1983-06-29 Shionogi & Co Ltd ニフエジピン固型製剤組成物
JPS6038322A (ja) * 1983-08-11 1985-02-27 Fujisawa Pharmaceut Co Ltd ジヒドロピリジンａ物質含有易溶性固形製剤
US5028433A (en) * 1988-11-30 1991-07-02 Banyu Pharmaceutical Co., Ltd. Readily absorbable drug formulation of NB-818

Also Published As

Publication number Publication date
ES2126579T3 (es) 1999-04-01
JP3110794B2 (ja) 2000-11-20
ATE175874T1 (de) 1999-02-15
EP0521310B1 (en) 1999-01-20
JPH04360833A (ja) 1992-12-14
EP0521310A2 (en) 1993-01-07
KR100209201B1 (ko) 1999-07-15
EP0521310A3 (en) 1994-10-05

Similar Documents

Publication Publication Date Title
DK0521310T3 (da) Tabletter af faststofdispersionstypen indeholdende 1,4-dihydropyridin-derivater samt fremgangsmåde til fremstilling af såda
PT88410A (pt) Process for preparing thiazolidinedione derivatives
NO177535C (no) Analogifremgangsmåte for fremstilling av terapeutisk aktive peptidforbindelser
CA2262502A1 (en) 6-phenyltetrahydro-1,3-oxazin-2-one derivatives and pharmaceutical composition containing the same
DE3873612D1 (de) Dithioacetal-verbindungen, verfahren zu deren herstellung und diese enthaltende pharmazeutische zusammensetzungen.
DE69016899D1 (de) Thiazolidinedionederivate.
NO178697C (no) Analogifremgangsmåte for fremstilling av terapeutisk aktive pyrazolopyridin-forbindelser
YU21597A (en) Metalloproteinase inhibitors, pharmaceutical compositions containing them and their pharmaceutical uses, and methods and intermediates useful for their preparation
DK66789D0 (da) Bicycloheptencarboxylsyrederivater
FI810604L (fi) Foerfarande foer framstaellning av indanderivat
ATE96772T1 (de) Substituierte 2-alkinylphenole mit entzuendungshemmender wirkung, verfahren zu deren herstellung und pharmazeutische zusammensetzungen.
DK96786A (da) Aminosyrederivater
FR2801587B1 (fr) Nouveaux derives de benzothiadiazines, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
KR910009672A (ko) 피리다진 유도체, 이의 제조방법 및 이것을 함유하는 약학 조성물
ES2056860T3 (es) Derivados de n-((2-oxopirrolidin-1-il)-acetil)piperazina y medicamento contra la demencia senil.
HUT64318A (en) Process for production benzodpyrane derivativs and pharmaceutical preparations containing these compounds as effective substance
ATE48994T1 (de) Benzimidazol-derivat, verfahren zu seiner herstellung und pharmazeutische zusammensetzung.
DE69110217D1 (de) Derivate der Kaffeinsäure und sie enthaltende pharmazeutische Zusammensetzungen.
NL8003803A (nl) Nieuwe zwavelhoudende isochinolinederivaten, deze ver- binding bevattende farmaceutische preparaten en werkwijze voor de bereiding van deze nieuwe ver- bindingen.
ATE50248T1 (de) Ein imidazolidintrion-derivat oder ein seiner pharmazeutisch akzeptierbaren salze enthaltende pharmazeutische zusammenstellung.
IL87174A (en) Benzimidazole derivatives, their preparation and pharmaceutical compositions containing them
US4351837A (en) 1,4-Dihydropyridine-3,5-dicarboxylate-4-carboxamide compounds, compositions containing same and method of using same
DE69024154D1 (de) Pyrimidoindolderivate und Verfahren zu ihrer Herstellung
KR910004614A (ko) 벤조티아진 유도체, 그의 제조방법 및 의약품 또는 의약품을 합성하기위한 중간물질로의 응용
KR860001947B1 (ko) 1,4-디히드로피리딘 유도체의 제조방법